Theranos whistleblower warns AI could make deception harder to detect
Tyler Shultz, a former Theranos employee who helped expose the company’s inaccurate blood-testing devices, says the lessons of the scandal remain relevant as artificial intelligence companies attract enormous valuations. Theranos reached about $10 billion despite its technology not functioning as claimed, and some tests were outsourced to third-party equipment. Its devices were used in Walgreens stores and produced faulty results for patients.